Moderna, Inc. (MRNA)
53.83
-3.97
(-6.87%)
USD |
NASDAQ |
Mar 05, 16:00
53.45
-0.38
(-0.71%)
After-Hours: 04:57
Moderna Cash from Investing (Quarterly) : -48.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -1.835B |
| Johnson & Johnson | -4.485B |
| Eli Lilly & Co. | -2.802B |
| Merck & Co., Inc. | -11.20B |
| Pfizer Inc. | -6.146B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 930.00M |
| Cash from Financing (Quarterly) | 581.00M |
| Free Cash Flow | -2.075B |
| Free Cash Flow Per Share (Quarterly) | 2.273 |
| Free Cash Flow to Equity (Quarterly) | 320.00M |
| Free Cash Flow to Firm (Quarterly) | 899.27M |
| Free Cash Flow Yield | -9.91% |